Home/Peptomyc/Jörg Klumbis

JK

Jörg Klumbis

Chief Financial Officer

Therapeutic Areas

Peptomyc Pipeline

Drug	Indication	Phase
OMO-103	Advanced Solid Tumors	Phase 1
OMO-103 + SOC	Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)	Phase 1b

Leadership Team at Peptomyc

Jesús Martín García

Chief Executive Officer

Dr. Laura Soucek

Chief Scientific Officer & Co-Founder

Dr. Marie-Eve Beaulieu

Chief Development Officer & Co-Founder

Chief Medical Officer

View full Peptomyc profile